Ardelyx (ARDX) EBITDA Margin Growth (5y) (2018 - 2026)
Ardelyx (ARDX) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ardelyx |
1.49 Bn |
1.25 Bn |
89.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
46,362.00 |
| Dec 31, 2025 |
160,117.00 |
| Sep 30, 2025 |
65,208.00 |
| Jun 30, 2025 |
132,000.00 |
| Mar 31, 2025 |
179,414.00 |
| Dec 31, 2024 |
88,273.00 |
| Sep 30, 2024 |
78,111.00 |
| Jun 30, 2024 |
14.14 Mn |
| Dec 31, 2023 |
3.27 Mn |
| Sep 30, 2023 |
1.40 Mn |
| Jun 30, 2023 |
7.40 Mn |
| Mar 31, 2023 |
50,028.00 |
| Jun 30, 2020 |
-138,951.00 |
| Mar 31, 2020 |
-179,039.00 |
| Dec 31, 2019 |
-81,679.00 |
| Sep 30, 2019 |
-78,271.00 |
| Jun 30, 2019 |
-14.15 Mn |
| Dec 31, 2018 |
-3.28 Mn |
| Sep 30, 2018 |
-1.40 Mn |
| Jun 30, 2018 |
-7.41 Mn |
